Although beneficial effects were previously found with AAT ASO treatment of liver disease, the knockdown of normal AAT may prove to be detrimental for the lung in the event of an injury with the overproduction of proteases, including chymotrypsin-like elastase 1 (Cela1), a digestive protease that is expressed during lung development [13]. This evidence concerns the gene SERPINA1 and liver disorder.